Mitophagy is essential for cellular homeostasis, but how mitophagy is regulated is largely unknown. Here we found that the kinase Jnk2 was required for stress-induced mitophagy. Jnk2 promoted ubiquitination and proteasomal degradation of the small mitochondrial form of the tumor suppressor ARF (smARF). Loss of Jnk2 led to the accumulation of smARF, which induced excessive autophagy that resulted in lysosomal degradation of the mitophagy adaptor p62 at steady state. Depletion of p62 prevented Jnk2-deficient cells from mounting mitophagy upon stress. Jnk2-deficient mice displayed defective mitophagy, which resulted in tissue damage under hypoxic stress, as well as hyperactivation of inflammasomes and increased mortality in sepsis. Our findings define a unique mechanism of maintaining immunological homeostasis that protects the host from tissue damage and mortality.
A r t i c l e s
Mitophagy, a selective form of autophagy that removes damaged or excessive mitochondria, is essential for maintaining cellular energy homeostasis and functions 1,2 . Deregulation of mitophagy has been linked to many pathophysiological activities and diseases 1,2 . Accumulating evidence suggests that mitophagy has a crucial role in the regulation of immune responses [3] [4] [5] . Defects in the clearance of damaged mitochondria by mitophagy result in the production of excessive reactive oxygen species (ROS) and damage-associated molecular patterns, which leads to hyperactivation of the NLRP3 inflammasome, which can induce tissue and organ damage and increased mortality in the host [3] [4] [5] .
The mitophagy machinery has been investigated extensively, but details of the mechanism by which it acts are still largely unclear. A prominent theme is that the E3 ubiquitin ligase parkin and the kinase PINK1 ('tumor suppressor PTEN-induced putative kinase 1') mediate the priming of damaged mitochondria for mitophagy [6] [7] [8] [9] . PINK1 is constitutively degraded in healthy mitochondria but is stabilized on the outer membrane of damaged mitochondria, where it recruits and activates parkin by phosphorylating Ser65 of parkin [6] [7] [8] [9] . Activated parkin ubiquitinates mitochondrial substrates, which in turn trigger translocation of the ubiquitin and autophagy markers and LC3-binding adaptors p62 (sequestosome-1 (SQSTM1)) or NBR1 to damaged mitochondria for the subsequent formation of autophagosome that will fuse with the lysosome (autolysosome) for degradation 1, 2, 6, 8, [10] [11] [12] [13] [14] [15] [16] . p62 itself is degraded together with enveloped cytosolic contents in the autolysosome during autophagy and mitophagy and thus serves as a marker of autophagy, but its abundance is restored at later phase of autophagy and mitophagy through transcriptional upregulation 17, 18 .
Small mitochondrial ARF (smARF) is a short isoform of the tumor suppressor ARF produced by alternative translational initiation at Met45; it localizes exclusively to mitochondria 19, 20 . The abundance of smARF in steady-state conditions is extremely low due to constant degradation by the proteasome [19] [20] [21] . Analyses using ectopic expression approaches have reported that overexpression of smARF is able to induce mitochondrial depolarization and subsequent autophagy and mitophagy 19, 20, 22 . However, the pathophysiological function and regulation of endogenous smARF is not known.
The Jnk ('c-Jun amino-terminal kinase'; stress-activated protein kinase (SAPK)) 23 kinases are a subfamily of the mitogen-activated protein kinase superfamily. Jnk is involved in the regulation of many cellular activities, from gene expression to apoptosis [23] [24] [25] . Jnk has two ubiquitously expressed isoforms, Jnk1 and Jnk2, which share 83% amino acid identity and have shared and distinct functions [23] [24] [25] . Jnk1 is the main isoform of Jnk that is activated by a variety of extracellular stimuli, whereas Jnk2 activity is negligible 26 . Instead, in unstimulated cells, Jnk2 targets its substrates, including c-Jun, ATF-2 and p53, for proteasomal degradation independently of its kinase activity [27] [28] [29] [30] [31] . It has been reported that Jnk1, but not Jnk2, contributes to starvationinduced autophagy by phosphorylating the antiapoptotic protein Bcl-2, which leads to its dissociation from the autophagy protein beclin-1 (ref. 32) . However, it is not known whether these two Jnk isoforms regulate mitophagy. Here we found that Jnk2 promoted ubiquitination-dependent proteasomal degradation of endogenous smARF, which otherwise triggered lysosomal degradation of p62 through augmentation of steady-state autophagy. Jnk2-deficient mice displayed defective mitophagy, which resulted in tissue damage under hypoxic stress and hyperactivation of inflammasomes and increased mortality during sepsis.
RESULTS

Stress-induced mitophagy requires Jnk2
To understand the role of Jnk in regulation of stress-induced mitophagy, we used Jnk1-or Jnk2-deficient mouse embryonic fibroblasts (MEFs). Immunoblot analysis showed that mitochondrial proteins (Tom20 for the outer membrane; TIM23 and/or ATP5β for the inner membrane; and cytochrome C and/or hsp60 for mitochondrial matrix) were much less abundant in wild-type fibroblasts cultured under hypoxic conditions or treated with the protonophore CCCP (carbonyl cyanide m-chlorophenyl hydrazone) or starved by incubation in HBSS (Hank's balanced salt solution) than in wild-type cells cultured in complete growth medium under normoxic conditions (without CCCP treatment) (Fig. 1a,b and Supplementary  Fig. 1a) , consistent with published reports [33] [34] [35] [36] . The decrease was caused by mitophagy, as it was prevented by bafilomycin A1, a lysosomal inhibitor of ATPase ( Supplementary Fig. 1b,c) . Under the same conditions, the decrease in mitochondrial proteins was inhibited in Jnk2-deficient (Mapk9 −/− ; called 'Jnk2 −/− ' here) MEFs but not in Jnk1-deficient (Mapk8 −/− ; called 'Jnk1 −/− ' here) MEFs (Fig. 1a,b and Supplementary Fig. 1d-g ). The ratio of punctation with green fluorescent protein (GFP)-tagged LC3 that localized with mitochondria was significantly lower in Jnk2 −/− MEFs than in wild-type fibroblasts (Fig. 1c,d) . We also demonstrated defects in mitochondrial clearance in Jnk2 −/− cells by immunofluorescence microscopy with antibody to Tom20 (anti-Tom20) (Fig. 1e,f ) and transmission electron microscopy ( Fig. 1g) . Ectopic expression of hemagglutinin (HA)-tagged Jnk2 restored mitophagy in Jnk2 −/− MEFs ( Supplementary Fig. 1h-j) , which suggested that the loss of Jnk2, rather than other genetic alterations, was responsible for the defective mitophagy. Furthermore, Jnk2 −/− MEFs produced excessive mitochondrial ROS (Fig. 1h) , indicative of the accumulation of damaged mitochondria. Notably, the general autophagy activity induced by hypoxia or HBSS was not altered by loss of Jnk2, as indicated by formation of the lipidated form of LC3 (LC3(II)) ( Supplementary  Fig. 1k ). Together these data suggested that Jnk2 was required for stress-induced mitophagy.
Jnk2 is essential for maintaining p62 abundance at steady state The initiation of mitophagy is mediated by the stabilization of PINK1 and translocation of parkin to the mitochondrial outer membrane [6] [7] [8] [9] . We assessed these two events in wild-type and Jnk2 −/− MEFs under hypoxic conditions or following treatment with CCCP. There were no substantial differences between wild-type MEFs and Jnk2 −/− MEFs under either condition in their stabilization of PINK1 ( Supplementary Fig. 2a,b) or recruitment of parkin to mitochondria ( Supplementary Fig. 2c ). p62 is specifically needed to mediate mitophagy but is dispensable for general autophagy 1, 2, 6, 8, [10] [11] [12] [13] [14] [15] [16] [17] . We sought to determine whether Jnk2 might regulate mitophagy by affecting p62 expression. As expected, expression of p62 was much lower in wild-type fibroblasts under hypoxic conditions than in normoxia and was much lower after stimulation with CCCP or A r t i c l e s HBSS than before such stimulation ( Fig. 2a-c) , consistent with published reports that p62 is degraded together with enveloped cytosolic contents in the autolysosome during autophagy 17 . Notably, the steady-state abundance of p62 was considerably lower in Jnk2 −/− MEFs than in wild-type MEFs (Fig. 2a-c) . We obtained similar results when we silenced Jnk2 through the use of Jnk2-specific small interfering RNA (siRNA) (Fig. 2d) . Conversely, ectopic expression of HA-Jnk2 restored the steady-state abundance of p62 in Jnk2 −/− MEFs (Fig. 2e) . Under our experimental conditions, p62 was required for mitophagy induced by hypoxia, CCCP or HBSS, as indicated by the observation that silencing of the gene encoding p62 significantly inhibited the degradation of Tom20 in response to hypoxia, CCCP or HBSS (Fig. 2f-h ). More notably, ectopic expression of Xpress-tagged p62 restored the degradation of Tom20 in Jnk2 −/− MEFs in response to hypoxia, CCCP or HBSS (Fig. 2i-k) . Thus, these data demonstrated that loss of Jnk2 substantially diminished the steady-state abundance of p62, which resulted in defective mitophagy upon stress.
Jnk2 suppresses excessive autophagy at steady state p62 is degraded together with enveloped cytosolic contents in the autolysosome during the induction of autophagy and thus serves as A r t i c l e s a marker of autophagy. The steady-state abundance of p62 is strictly regulated by degradation via steady-state autophagy 1, 2, 16, 20, [22] [23] [24] [25] [26] [27] [28] [29] 37 . We investigated whether loss of Jnk2 triggered more autophagy during basal conditions to enhance the degradation of steady-state p62, which would result in subsequently defective mitophagy upon stress. Real-time RT-PCR revealed that the abundance of p62 mRNA was similar in wild-type and Jnk2 −/− fibroblasts ( Supplementary Fig. 3 ). However, treatment of Jnk2 −/− MEFs with bafilomycin A1 led to accumulation of p62 to amounts similar to those in wild-type fibroblasts cultured under similar conditions (Fig. 3a) ; this indicated enhanced lysosomal degradation of p62 in the absence of Jnk2. Consistent with that, LC3(II) formation and GFP-LC3 punctation were greater in Jnk2 −/− MEFs than in wild-type fibroblasts under unstimulated conditions (Fig. 3b,c) . We obtained similar results when we silenced Jnk2 through the use of Jnk2-specific siRNA (Fig. 3d) . Ectopic expression of HA-Jnk2 in Jnk2 −/− MEFs diminished the steady-state autophagy to a level similar to that observed in wildtype fibroblasts (Fig. 3e) . Furthermore, silencing of genes encoding the essential autophagy-associated molecules beclin-1 or Atg5 restored p62 protein expression in Jnk2 −/− MEFs (Fig. 3f,g ). These data together suggested that the enhanced steady-state autophagy in Jnk2 −/− MEFs was responsible for the lower steady-state expression of p62, which prevented these cells from mounting efficient mitophagy upon stress.
Loss of Jnk2 stabilizes smARF
The enhanced steady-state autophagy in Jnk2 −/− MEFs might have resulted from increased expression of genes encoding pro-autophagy molecules, such as beclin-1 or Atg5. This possibility was not the case, since there was no detectable difference between wild-type and Jnk2 −/− fibroblasts in their abundance of beclin-1 or Atg5 protein (Supplementary Fig. 4a ). It has been reported that overexpression of smARF potently induces autophagy and mitophagy 19 . We found that expression of smARF protein was barely detectable in wild-type fibroblasts (Fig. 4a) , consistent with published reports that smARF is quickly turned over through proteasomal degradation at steady state 19 . In contrast, the abundance of smARF protein was much greater in Jnk2 −/− MEFs than in wild-type MEFs at steady state (Fig. 4a) . We confirmed the identity of smARF in Jnk2 −/− MEFs by several approaches. First, two siRNAs targeting different positions on mRNA encoding ARF were able to reduce the expression of both full-length ARF (p19ARF) and smARF in Jnk2 −/− MEFs (Supplementary Fig. 4b) . Second, immunoblot analysis with an antibody that recognizes an epitope in the carboxyl terminus of ARF different from the epitope recognized by the anti-ARF used in our other studies also revealed more abundance of smARF in Jnk2 −/− MEFs ( Supplementary Fig. 4c ). Finally, mass spectrometry of smARF proteins immunoprecipitated from Jnk2 −/− MEFs recovered a peptide with the sequence LPGHAGGAAR, which is part of p19ARF
Cyto Mito A Fig. 4d ). The accumulated smARF was targeted exclusively to the mitochondria in Jnk2 −/− MEFs (Fig. 4b) , consistent with published reports showing that smARF is localized to mitochondria 19 . We obtained similar results by silencing Jnk2, but not by silencing Jnk1 (Fig. 4c and Supplementary Fig. 4e ). Silencing of Jnk2 also enhanced the abundance of exogenous Xpress-tagged smARF (Supplementary Fig. 4f) . Conversely, expression of exogenous HA-Jnk2 substantially diminished the abundance of smARF protein in Jnk2 −/− MEFs (Fig. 4d) .
Next we investigated whether the kinase activity of Jnk2 was required for its regulation of smARF. Like the expression of wild-type Jnk2, the expression of either of two kinase activity-deficient mutants of Jnk2 reduced the amount of smARF protein in Jnk2 −/− MEFs (Fig. 4e) , which suggested that the kinase activity of Jnk2 was not required for its regulation of smARF expression. Jnk1 activity is enhanced in unstimulated Jnk2 −/− MEFs 26 . It is plausible that the accumulated smARF proteins in Jnk2 −/− MEFs were the result of increased Jnk1 activity. However silencing of Jnk1 in Jnk2 −/− MEFs did not affect the expression of smARF protein (Supplementary Fig. 4g) . Thus, the enzymatic activity of Jnk was not involved in regulating the stability of smARF protein.
To determine whether increased abundance of smARF was responsible for the enhanced degradation of steady-state p62 in Jnk2 −/− MEFs, we silenced the gene encoding ARF (Cdkn2a; called 'Arf' here) in Jnk2 −/− MEFs. Since smARF is the product of alternative translational initiation of ARF, Arf-specific siRNA will affect both full-length p19ARF and smARF. To avoid the influence of Arf-specific siRNA on the expression of full-length p19ARF, we transfected Jnk2 −/− MEFs with Arf-specific siRNA at a relatively low dose (20 nM) that substantially decreased the expression of smARF but not of full-length p19ARF (Fig. 4f,g ). Under these conditions, p62 protein was stabilized ( Fig. 4f) , while the enhanced formation of LC3(II) and GFP-LC3 punctation was diminished in Jnk2 −/− MEFs (Fig. 4g,h) . Thus, smARF may have accounted for the greater autophagy activity and lower p62 abundance in Jnk2 −/− MEFs at steady state. In further support of that notion, expression of p62 protein was higher in Arf −/− MEFs than in wild-type MEFs but was diminished to amounts similar to those of wild-type MEFs in Arf −/− MEFs transfected with either an expression vector encoding p19ARF, which generated full-length p19ARF and smARF, or an expression vector encoding smARF (Fig. 4i) .
However, complementation of Arf −/− cells with mutant ARF in which the methionine at position 45 was replaced with isoleucine, and thus only full-length p19ARF was generated, did not diminish the steadystate abundance of p62 (Supplementary Fig. 4h) . Furthermore, transfection with Arf-specific siRNA at a low dose that substantially decreased the expression of smARF but not of full-length p19ARF restored mitophagy in Jnk2 −/− MEFs in response to hypoxia, CCCP or HBSS (Fig. 4j) . Finally, in Arf −/− MEFs, the steady-state expression of p62 and stress-induced mitophagy were not affected by silencing of Jnk2 (Supplementary Fig. 4i ). Together these data suggested that stabilization of smARF in the absence of Jnk2 was mainly responsible for the excessive autophagy and subsequently lysosomal degradation of p62 at steady state, which led to defective mitophagy under stress.
Jnk2 promotes ubiquitination and degradation of smARF
The steady-state expression of smARF was extremely low in wild-type fibroblasts and became detectable only when cells were treated with the proteasome inhibitor MG-132, but not when they were treated with bafilomycin A1 (Fig. 5a and Supplementary Fig. 5a ), consistent with a published report showing that smARF is rapidly degraded by the proteasome in unstimulated cells 19 . In contrast, MG-132 was unable to further increase the abundance of smARF protein in Jnk2 −/− MEFs (Fig. 5a ). This finding was not the result of defect in proteasome activity in Jnk2 −/− fibroblasts, as shown by the abundance of the hypoxia-inducible factor HIF-1α before and after hypoxia treatment, as well as degradation of the inhibitor IκBα induced by tumor-necrosis factor (Supplementary Fig. 5b,c) . The half-life of smARF was much greater in Jnk2 −/− MEFs than in wild-type fibroblasts (Fig. 5b) , and the rapid turnover of smARF in wild-type fibroblasts was inhibited by MG-132 (Fig. 5c) . These data suggested that Jnk2 promoted the proteasomal degradation of steady-state smARF.
To determine whether Jnk2 triggered the ubiquitination-dependent proteasomal degradation of smARF, we generated wild-type fibroblasts that stably expressed Xpress-tagged smARF and transfected the cells with Jnk2-specific siRNA or nontargeting (control) siRNA. We analyzed ubiquitination of Xpress-tagged smARF by immunoprecipitation with antibody to the Xpress tag, followed by immunoblot analysis with antibody to total ubiquitin or the antibody to Lys48 (K48) linkage-specific ubiquitin. Silencing of Jnk2 significantly A r t i c l e s decreased the K48-linked polyubiquitination of smARF (Fig. 5d,e) . Co-immunoprecipitation assays showed that smARF specifically interacted with ectopically expressed Jnk2 but not Jnk1 ( Fig. 5f and Supplementary Fig. 5d ), as well as with endogenous Jnk2 (Fig. 5g) . Jnk2 partially localized in mitochondria, where smARF exclusively resides, at steady state ( Supplementary Fig. 5e ), which suggested that Jnk2 might target smARF for proteasomal degradation in the mitochondria. Although Jnk2 also interacted with full-length p19ARF (Supplementary Fig. 5f ), it did not affect the ubiquitination of p19ARF (Supplementary Fig. 5g ). Together these data suggested that Jnk2 facilitated K48-linked polyubiquitination of smARF to promote its proteasomal degradation.
Jnk2 prevents hypoxia-induced tissue damage
To understand the role of Jnk2 in stress-induced mitophagy, we used hypoxia as an in vivo model. We exposed wild-type and Jnk2 −/− mice to normoxia (21% O 2 ) or hypoxia (7% O 2 ) for 1, 4 or 7 d. The expression of Tom20 protein gradually decreased in the heart and lungs of hypoxic wild-type mice (Fig. 6a,b) . In contrast, the degradation of Tom20 was inhibited in the heart and lungs of hypoxic Jnk2 −/− mice (Fig. 6a,b) . Dual immunofluorescence staining of heart and lungs from hypoxic wild-type mice showed co-localization of LC3 puncta with mitochondria; this was substantially diminished in Jnk2 −/− mice (Fig. 6c,d ). Histology analysis revealed more obvious damage in the heart and lungs of hypoxic Jnk2 −/− mice than in those of their wild-type counterparts (Fig. 6e,f) . We also observed less p62 protein and more accumulation of smARF in the heart and lungs of Jnk2 −/− mice than in those of wild-type mice at steady state ( Supplementary  Fig. 6a,b) . Together these data indicated that Jnk2 functioned as a guardian to protect organs such as heart and lung from hypoxiainduced damage through the promotion of mitophagy.
Jnk2 suppresses activation of inflammasomes
Defective mitophagy has been reported to induce excessive mitochondrial ROS, which leads to the hyperactivation of inflammasomes and elaboration of mature interleukin 1β (IL-1β) [3] [4] [5] . To determine the role of Jnk2-mediated mitophagy in regulating the activation of inflammasomes, we isolated bone marrow-derived macrophages (BMDMs) from wild-type and Jnk2 −/− mice, primed the cells with lipopolysaccharide (LPS) and then stimulated them with ATP to activate inflammasomes 5 . Under these conditions, Jnk2 −/− BMDMs secreted significantly more IL-1β and IL-18, as well as active, cleaved caspase-1 and IL-1β, than did wild-type BMDMs (Fig. 7a,b) . The enhanced inflammasome activity in the Jnk2 −/− BMDMs was not the result of altered activation of upstream signaling molecules, including the transcription factor NF-κB and kinases p38 and Erk, as activation of these molecules was similar in wild-type and Jnk2 −/− BMDMs (Supplementary Fig. 7a ). Consistent with that, treatment with LPS plus ATP induced mitophagy in wild-type BMDMs but not in Jnk2 −/− BMDMs, as shown by immunoblot analysis with anti-Tom20 and the colocalization of LC3 puncta with mitochondria ( Fig. 7c,d ).
Under the same conditions, the amount of mitochondrial ROS in Jnk2 −/− BMDMs was greater than that in wild-type BMDMs (Fig. 7e) . Treatment with Mito-TEMPO, an antioxidant targeted to mitochondria that is a scavenger specific for mitochondrial ROS 5 , abrogated the increase in the secretion of IL-1β and IL-18 in Jnk2 −/− BMDMs in response to LPS plus ATP (Fig. 7f) . Furthermore, ectopic expression of p62 inhibited the enhanced secretion of IL-1β and IL-18 in Jnk2 −/− BMDMs in response to LPS and ATP ( Fig. 7g and Supplementary  Fig. 7b ). The partial inhibition of the enhanced secretion of IL-1β and IL-18 in Jnk2 −/− BMDMs by p62 was most probably due to the relatively low transduction efficiency of the p62-expressing lentivirus (~30%). Silencing of Jnk2 in the mouse alveolar macrophage cell line MH-S also enhanced the secretion of IL-1β and IL-18 in response to LPS plus ATP (Supplementary Fig. 7c) . Similarly, the addition of antimycin A or rotenone, which inhibit the mitochondrial respiratory complex I or complex III, respectively, induced more secretion of IL-1β and IL-18 and/or production of mitochondrial ROS in LPS-primed Jnk2 −/− BMDMs than in their wild-type counterparts ( Supplementary Fig. 7d,e) .
To further determine the in vivo relevance of the regulation of inflammasome activation by Jnk2, we used an animal model of A r t i c l e s endotoxic shock. Consistent with the in vitro results, serum concentrations of IL-1β and IL-18 were significantly higher in endotoxemic Jnk2 −/− mice than in their wild-type counterparts (Fig. 7h) . Jnk2 −/− mice were more susceptible to LPS-induced mortality than were wild-type mice (Fig. 7i) . Jnk2 −/− BMDMs also had less p62 protein and more smARF protein at steady state than did wild-type BMDMs (Supplementary Fig. 7f ). Together these data demonstrated that loss of Jnk2 resulted in the hyperactivation of inflammasomes.
Erythroid maturation does not require Jnk2
Mitophagy is critical for the coordinated removal of mitochondria during the terminal differentiation of erythrocytes. We found that red blood cell (RBC) counts and the concentration of hemoglobin and hematocrit in the peripheral blood were similar in wild-type mice and Jnk2 −/− mice (Supplementary Fig. 7g ). We also examined RBCs for expression of the erythroid cell marker Ter119 and the transferrin receptor CD71 (which is downregulated during terminal erythrocyte differentiation). The frequency of Ter119 + CD71 + reticulocytes and mature CD71 − erythrocytes in the blood was also similar in wild-type and Jnk2 −/− mice (Supplementary Fig. 7h ). In addition, there were similar populations of CD71 − RBCs negative for the mitochondrial stain MitoTracker Green, as well as CD71 + RBCs positive for MitoTracker Green, in wild-type and Jnk2 −/− mice (Supplementary Fig. 7i ). These data suggested that loss of Jnk2 did not affect erythrocyte differentiation at steady state, which indicated different roles for Jnk2 in mitophagy under stress and in developmental conditions.
DISCUSSION
Overwhelming evidence has shown a fundamental role for mitophagy in many physiological events, from development to aging, and its deregulation contributes to many diseases, including neurodegenerative diseases and immunological disorders [1] [2] [3] [4] [5] . Although a series of key components in the mitophagy machinery have been identified [6] [7] [8] , how mitophagy is regulated has remained largely unknown. In this report, we demonstrated that Jnk2 was required for stress-induced mitophagy through the promotion of ubiquitination-dependent proteasomal degradation of smARF. Loss of Jnk2 resulted in tissue damage under hypoxic stress, as well as inflammasome hyperactivation and increased mortality in sepsis. Thus, Jnk2 functions as a guardian for organ integrity and thereby determines life or death under environmental stress. Jnk2 positively regulated stress-induced mitophagy through targeting smARF for degradation independently of its kinase activity. It has been reported that Jnk1 is involved in starvation-induced autophagy through phosphorylation of Bcl-2 and inhibition of its association with beclin-1 (ref. 32). Our results have provided genetic evidence that Jnk2, but not Jnk1, targeted smARF for ubiquitination-dependent proteasomal degradation at steady state in a kinase activityindependent manner and thereby ensured that cells mounted efficient mitophagy to eliminate damaged mitochondria under stress in vitro and in vivo. Although the underlying mechanism by which Jnk2 targets smARF for ubiquitination has yet to be determined, our observation that Jnk2 interacted with smARF would suggest that Jnk2 might act as an adaptor to facilitate the interaction of smARF with its E3 ligase. The cellular compartment in which Jnk2 targets smARF for proteasomal degradation also remains to be determined. However, our results showed that Jnk2 localized to the mitochondria, where smARF exclusively resides. Therefore, it is possible that Jnk2 might target smARF for proteasomal degradation in mitochondria. Although Jnk2 also interacted with full-length p19ARF, it did not affect the ubiquitination of p19ARF. It is possible that the amino-terminal region of p19ARF, A r t i c l e s which mediates its binding to many cofactors but is not present in smARF 38, 39 , may interfere with Jnk2-mediated ubiquitination of p19ARF. Although p19ARF contributes to autophagy when overexpressed or under pathological conditions such as oncogenic stress or in cancer cells 22, 40, 41 , the slightly increased abundance of p19ARF in Jnk2 −/− cells is less likely to have been accountable for the enhanced autophagy and decreased p62 expression at steady state, as complementation of Arf −/− cells with mutant ARF that generated only full-length p19ARF did not reduce the steady-state abundance of p62. Thus, smARF might have had a dominant role in the enhanced autophagy in Jnk2-deficient cells.
The ubiquitin-and LC3-binding adaptor p62 was essential for the promotion of stress-induced mitophagy by Jnk2. The role of p62 in mitophagy has been controversial. While it has been reported that p62 is critical for the removal of depolarized mitochondria via mitophagy 1, 2, 6, 8, [11] [12] [13] [14] [15] [16] , it has also been shown that p62 is dispensable for mitophagy, possibly due to the redundancy with the related ubiquitinand LC3-binding protein NBR1 (refs. 2,42) . Our results showed that loss of Jnk2 enhanced the lysosomal degradation of steady-state p62, which resulted in defective mitophagy upon stress, while ectopic expression of p62 in Jnk2 −/− MEFs restored mitophagy in response to stress. Consistent with that, silencing of the gene encoding p62 resulted in defective mitophagy upon cellular stress. Thus, our studies demonstrated a crucial role for p62 in the Jnk2-mediated regulation of mitophagy upon stress.
smARF has a dual function in autophagy and mitophagy. Published studies have shown that ectopic overexpression of smARF is able to induce mitochondrial depolarization and autophagy and/or mitophagy 19 . However, the pathophysiological function of endogenous smARF is not known. Our results showed that loss of Jnk2 induced the accumulation of smARF, which resulted in more steadystate autophagy in unstimulated cells, consistent with published results obtained by ectopic overexpression of smARF 19 . Paradoxically, our results revealed that accumulated endogenous smARF in the absence of Jnk2 enhanced the steady-state autophagy that caused more lysosomal degradation of p62, which resulted in defective stressinduced mitophagy. Thus, the endogenous smARF that accumulated in the absence of Jnk2 regulated autophagy and mitophagy by two distinct but interrelated mechanisms: promotion of steady-state autophagy and suppression of stress-induced mitophagy.
We observed slightly more Tom20 protein at baseline in Jnk2-deficient cells, which was not 'rescued' by overexpression of p62. In addition, silencing of Jnk2 in Arf −/− MEFs still resulted in more Tom20 without a decrease in the abundance of p62 at steady state. In contrast, either ectopic expression of p62 or silencing of the gene encoding smARF restored the degradation of Tom20 in Jnk2-deficient cells in response to inducers of mitophagy, regardless of the basal amount of Tom20. Moreover, in Arf −/− MEFs, the stress-induced degradation of Tom20 and steady-state expression of p62 were not affected by silencing of Jnk2, although an increase in the basal abundance of Tom20 was caused by the knockdown of Jnk2 in these cells. Therefore, Jnk2 regulated stress-induced mitophagy via the smARF-p62 axis. It is likely that Jnk2 regulates basal Tom20 expression through a different mechanism, but this regulation is probably not involved in the regulation of stress-induced mitophagy by Jnk2.
Jnk2 is not required for erythroid maturation. It is known that mitophagy is critical for the elimination of mitochondria during erythroid maturation 43 . Our finding that Jnk2 was critical for mitophagy under stress conditions but not during erythroid maturation indicated that Jnk2 regulates mitophagy differently under stress conditions and developmental conditions. During reticulocyte maturation, it is possible that either Jnk2-maintained p62 is not required for this type of mitophagy or that its deficiency is compensated by other pathways, such as that of Nix, a mitochondrial protein that is able to directly bind to LC3 and whose expression substantially upregulated during terminal erythroid differentiation 43 .
Our findings have identified Jnk2 as a previously unknown key regulator of inflammasome activation. Our results showed that Jnk2 −/− BMDMs, which had defective stress-induced mitophagy and excessive ROS, had increased secretion of IL-1β and IL-18, as well as active caspase-1 and IL-1β, in response to LPS and ATP. More notably, Jnk2 −/− mice had increased concentrations of serum IL-1β and IL-18 and higher mortality rate, accompanied by impaired clearance of damaged mitochondria, compared with that of wild-type mice, in a mouse model of sepsis. Thus, the promotion of stressactivated mitophagy by Jnk2 might have a critical role in preventing the hyperactivation of inflammasomes. Sepsis represents an exaggerated systemic inflammatory response to infection that can progress to multi-organ failure, including shock 44, 45 . So far there is no effective treatment for sepsis. It has long been considered that sepsis is a condition associated with mitochondrial dysfunction, and a study of the metabolome and proteome in septic patients has revealed that mitochondrial dysfunction can serve as a signature indicative of the outcome of sepsis 46 . In support of that observation, a published report has shown that upregulation of autophagy not only inhibits inflammatory cytokine production but also confers tissue tolerance to damage in sepsis, which might represent an efficacious therapeutic option for sepsis 47, 48 . Thus, the promotion of mitophagy by Jnk2 might protect organs from sepsis-induced damage by at least two interrelated mechanisms: by suppressing inflammasome activation, and by conferring tissue tolerance to damage. Targeting both inflammation and tissue tolerance to damage by upregulating mitophagy may be critical to the prevention of sepsis-induced tissue damage and organ failure. It will be of interest to investigate whether Jnk2 is dysregulated during sepsis in mice. Furthermore, targeting Jnk2-regulated mitophagy for tissue tolerance to damage may have broad applications to many other pathological conditions that, like sepsis, are associated with mitochondrial dysfunction.
METHODS
Methods and any associated references are available in the online version of the paper. 
